Shameze Rampertab sold ASXC
February 4, 2024 · Form 4 insider transaction
Shameze Rampertab sold 62,417 shares of Asensus Surgical, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock.; Lapse of forfeiture restrictions on the second one-third of a RSU award granted on February 4, 2022. Forfeiture restrictions will lapse on the remaining RSUs on February 4, 2025, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement.